MedTrace Logo

Reducing Dialysate Sodium Effect on Blood Pressure Variability in Hemodialysis Patients

NCT05169125 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2021-12-23

No results posted yet for this study

Summary

In this study the investigators aim to test the effect of lowering dialysate sodium concentration on visit-to-visit blood pressure variability in hemodialysis patients who have achieved their dry weight.

Conditions

  • Hemodialysis Patients

Interventions

PROCEDURE

standard hemodialysis

patients who will undergo standard hemodialysis (dialysate sodium concentration 143 mmoL/L)

PROCEDURE

lower dialysate sodium dialysis

patients who will undergo hemodialysis with lower dialysate sodium concentration (140 mmoL/L)

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Ghada El-said, Ass. Prof. · Mansoura University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-31
Primary Completion
2022-05-31
Completion
2022-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05169125 on ClinicalTrials.gov